AHMEDABAD, India, November 5, 2018 /PRNewswire/ --
Veeda Clinical Research Pvt. Ltd., a leading independent CRO is proud to announce that our Shivalik, Insignia and Vedant (except bio analytical) facility had successfully completed fifth Inspection by WHO (World Health Organization) without any critical observations.
(Logo: https://mma.prnewswire.com/media/591114/Veeda_Clinical_Research_Pvt_Ltd_Logo.jpg )
After successful inspection by NPRA (Malaysian Regulatory Agency), Veeda CRO faced another Inspection in the same month by WHO. This inspection was the fifth WHO inspection at Veeda. WHO Inspectors did thorough inspection of all three Veeda facilities, wherein they reviewed various BE studies submitted as part of pre-qualification of BE-studies applications program. The Inspection team also covered various other study related activities as well as different facilities.
Veeda CRO have successfully faced 50 regulatory audits in last 13 years wherein 18 USFDA Inspections were conducted successfully in last 24 months which demonstrates our commitment levels towards Quality and Regulatory Compliance.
With an enhanced focus on 'Right First Time' approach, Veeda CR looks forward to a brighter future in Clinical Research Arena. These inspections are another testimony to Veeda CR's continuous quality review and improvement measures institutionalized into the work culture.
About Veeda CRO
Veeda CR is a full service CRO that conducts clinical research to support clients in their clinical programs. The company provides expert services in PK (pharmacokinetic) and PD (pharmacodynamics) studies in healthy volunteers; conducts patient trials in generic molecules and NCEs (new chemical entity) and undertakes research in Biopharmaceuticals. The company offers a fully integrated package which includes services on Phase I to Phase IV clinical trials in central nervous system, oncology, and other complex therapeutic areas. The company's services also include clinical trial management services comprising patient recruitment and retention, project management, clinical monitoring, drug safety/pharmacovigilance, medical affairs, quality assurance, and regulatory and medical writing to meet global clinical development needs.
Media Contact: Ms. Priyanka Tiwari Veeda Clinical Research Pvt. Ltd. Vedant Complex Beside YMCA Club S. G. Highway Vejalpur,Ahmedabad-380051 Gujarat India Phone: +91-79-3001-3000 Fax: +91-79-3001-3010 Email: [email protected]
Website: http://www.veedacr.com
.
SOURCE Veeda Clinical Research Pvt Ltd
Advertisement
Veeda Clinical Research Pvt. Ltd., a leading independent CRO is proud to announce that our Shivalik, Insignia and Vedant (except bio analytical) facility had successfully completed fifth Inspection by WHO (World Health Organization) without any critical observations.
Advertisement
(Logo: https://mma.prnewswire.com/media/591114/Veeda_Clinical_Research_Pvt_Ltd_Logo.jpg )
After successful inspection by NPRA (Malaysian Regulatory Agency), Veeda CRO faced another Inspection in the same month by WHO. This inspection was the fifth WHO inspection at Veeda. WHO Inspectors did thorough inspection of all three Veeda facilities, wherein they reviewed various BE studies submitted as part of pre-qualification of BE-studies applications program. The Inspection team also covered various other study related activities as well as different facilities.
Veeda CRO have successfully faced 50 regulatory audits in last 13 years wherein 18 USFDA Inspections were conducted successfully in last 24 months which demonstrates our commitment levels towards Quality and Regulatory Compliance.
With an enhanced focus on 'Right First Time' approach, Veeda CR looks forward to a brighter future in Clinical Research Arena. These inspections are another testimony to Veeda CR's continuous quality review and improvement measures institutionalized into the work culture.
About Veeda CRO
Veeda CR is a full service CRO that conducts clinical research to support clients in their clinical programs. The company provides expert services in PK (pharmacokinetic) and PD (pharmacodynamics) studies in healthy volunteers; conducts patient trials in generic molecules and NCEs (new chemical entity) and undertakes research in Biopharmaceuticals. The company offers a fully integrated package which includes services on Phase I to Phase IV clinical trials in central nervous system, oncology, and other complex therapeutic areas. The company's services also include clinical trial management services comprising patient recruitment and retention, project management, clinical monitoring, drug safety/pharmacovigilance, medical affairs, quality assurance, and regulatory and medical writing to meet global clinical development needs.
Media Contact: Ms. Priyanka Tiwari Veeda Clinical Research Pvt. Ltd. Vedant Complex Beside YMCA Club S. G. Highway Vejalpur,Ahmedabad-380051 Gujarat India Phone: +91-79-3001-3000 Fax: +91-79-3001-3010 Email: [email protected]
Website: http://www.veedacr.com
.
SOURCE Veeda Clinical Research Pvt Ltd
